Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Zapping the brain to prevent falls in seniors

NCT ID NCT03814304

Symptom relief Sponsor: Hebrew SeniorLife Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 2 times

Summary

This study tested whether a non-invasive brain stimulation technique called tDCS could improve balance and cognitive function in older adults who have fallen at least twice in the past year and are afraid of falling. Over 100 participants received either real or sham stimulation during 20 sessions over four weeks. The goal was to see if the treatment could help them walk and think at the same time more safely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

99 people

The number who actually took part.

Started

Jul 2019

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Men and women aged 60 or older * Self-report of mobility and balance problems * Self-report of fear of falling defined by a "yes" answer to the yes-or-no question "Is the participant worried about falling in the future?" * Trail Making Test (TMT) Part B time below 75th percentile of age-and education-based norms * A score of 10 or below on the Short Physical Performance Battery Exclusion Criteria: * Inability to stand or walk unassisted for 60 seconds * Hospitalization within the past three months due to acute illness, or as the result of a musculoskeletal injury significantly affecting gait or balance * Any unstable medical condition * a diagnosis of a gait disorder, Parkinson's disease, Alzheimer's disease or dementia, multiple sclerosis, previous stroke or other neurodegenerative disorder * Chronic vertigo * Myocardial infarction within the past 6 months * Active cancer for which chemo-/radiation therapy is being received * Psychiatric co-morbidity including major depressive disorder, schizophrenia or psychosis * Chronic use of any sedating medications (sedatives, anti-psychotics, hypnotics, anti-depressants) or change in medication within the previous month * Legal blindness * Contraindications to MRI or tDCS, including reported seizure within the past two years, use of neuro-active drugs, the risk of metal objects anywhere in the body, self-reported presence of specific implanted medical devices (e.g., deep brain stimulator, medication infusion pump, cochlear implant, pacemaker, etc.), or the presence of any active dermatological condition, such as eczema, on the scalp * A score below 22 on the Telephone Interview of Cognitive Status (TICS) * Mild or severe dementia defined by a Clinical Dementia Rating (CDR) score of one or greater

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Accidental falls are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Accidental falls Aging

Contacts and locations

Locations

  • Hebrew Rehabilitation Center

    Roslindale, Massachusetts, 02131, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.